PALACE CAPITAL PLC

Declaration of Voting Results & Voting Rights Announcements • Nov 30, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1231J

Palace Capital PLC

30 November 2018

Palace Capital PLC

("Palace Capital" or the "Company")

Total Voting Rights

Palace Capital, the property investment company that focuses on commercial property outside London, announces that the Company's issued share capital as at the date of this announcement comprises 45,843,866 ordinary shares, with one voting right per share ("Ordinary Shares"). This figure excludes the 544,649 Ordinary Shares held in treasury.

The above figure of 45,843,866 Ordinary Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquires:

Neil Sinclair, Chief Executive

Stephen Silvester, Finance Director

David Kaye, Company Secretary

Tel: + 44 (0)20 3301 8330

Date: 30 November 2018

About Palace Capital PLC:

Palace Capital plc (LSE: PCA) is a Main Market listed property investment company that has a £283.3 million diversified portfolio of UK regional commercial property. The Company maintains a disciplined investment strategy focused on towns and cities outside of London that are characterised by thriving local economies and strengthening fundamentals. Within those locations, the highly experienced management team selects assets that provide opportunity to drive both capital value and long term rental income through tailored active asset management programmes, ultimately delivering attractive shareholder returns.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

TVRFMMFMVGVGRZM